In our previous work in AD, we hypothesized that nucleolar down-regulation of PARP-1 is an early event in AD leading to activation of Dnmt1, the silencing of rDNA, and as a consequence, memory deficits [22]. This evidence concerns the gene DNMT1 and Alzheimer disease.